Inflammation, insulin resistance and carotid IMT in first degree relatives of north Indian type 2 diabetic subjects

Diabetes Research and Clinical Practice

Volumn 73, Issue 2, 2006, Pages 205-210

  Ahmad, Jamal ^a   Ahmed, Faiz ^a   Siddiqui, Mohammad A ^a   Hameed, Basharat ^a   Ahmad, Ibne ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Carotid IMT; First degree relatives; Inflammation; Insulin resistance; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; INDIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTIMA; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THICKNESS; TUNICA MEDIA;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CAROTID ARTERIES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; OBESITY; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; TUNICA MEDIA;

EID: 33745256460     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.01.009     Document Type: Article

References (26)

1. Stewart M.W., Humphris D.B., Berrish T.S., Barriocanal L.A., Trajano L.R., Alberti K.G.M.M., et al. Features of syndrome X in first degree relatives of NIDDM patients. Diab. Care 18 (1995) 1020-1022
2. Haffner S.M., Stern M.P., and Hazuda H.P. Parental history of diabetes is associated with increased cardiovascular risk factor. Atherosclerosis 9 (1989) 928-933
3. Shaw J.T.E., Purdie D.M., Neil H.A.W., Levy J.C., and Turner R.C. The relative risk of hyperglycemia, obesity and dyslipidemia in the relatives of pts of type 2 diabetes mellitus. Diabetologia 42 (J) (1999) 24-27
4. Laakso M., and Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 137 (1998) S65-S73
5. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diab. Care 2 (1993) 434-444
6. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with Type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. New Engl. J. Med. 339 (1998) 229-234
7. Ramachandran A., Snehlatha C., Bhaskar A.D., Mary S., Kumar C.K., Selvam S., et al. Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in rural population in India. Diabetologia 47 (2004) 860-865
8. Vishwanathan M., Mohan V., Snehlatha C., and Ramachandran A. High prevalence of Type 2 (non-insulin dependent) diabetes among offspring of conjugal diabetic parent in India. Diabetologia 28 12 (1985) 907-910
9. Crook M.A. Type 2 diabetes a disease of innate immune system? An update. Diabet. Med. 21 (2004) 203-207
10. Haffner S.M. Insulin resistance, inflammation and the prediabetic state. Am. J. Cardiol. 92 Suppl. 4 (2003) 18J-26J
11. Pickup J., and Crook M. Is Type 2 diabetes mellitus a disease of the innate immune system?. Diabetologia 41 (1998) 1241-1248
12. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102 (2000) 42-47
13. Nakanishi S., Yamane K., Kamel N., Okubo M., and Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diab. Care 26 (2003) 2754-2757
14. Thorand B., Lowel H., Schneider A., Kolb H., Meisinger H.C., Frohlich M., et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Ausburg cohort study. Arch. Intern. Med. 163 (2003) 93-99
15. Dandona P., Weinstock R., Thusu K., Abdel-Rahman E., Aljada A., and Wadden T. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 83 (1998) 2907-2910
16. Mansfield M.W., Heywood D.M., and Grant P.J. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 94 9 (1996) 2171-2176
17. Aminbakhash A., and Mancini G.B. Carotid intima media thickness measurements: what defines an abnormality? A systemic review. Clin. Invest. Med. 4 (1999) 149-157
18. World Health Organization. Definition Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus (1999), World Health Organisation, Geneva
19. Alberti K.G.M.M., and Zimmet P.Z. The World Health Organization (WHO) consultation: definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO Consultation. Diabet. Med. 15 (1998) 539-553
20. Friedewald W.T., Levy R.I., and Friedrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
21. Kriketos A.D., Greenfield J.R., Peake P.W., Furler S.M., Denyer G.S., Charlesworth J.A., et al. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diab. Care 27 (2004) 2033-2040
22. Pannacciulli N., De Pergola G., Giorgino F., and Giorgino R. A family history of type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women. Diabet. Med. 19 8 (2002) 689-692
23. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. CRP and its relation to cardiovascular risk factors, a population based cross sectional study. BMJ 312 (1996) 1061-1065
24. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. Production of CRP and risk of coronary events in stable and unstable angina European concerted action on thrombosis and disabilities angina pectoris study group. Lancet 349 (1997) 462-466
25. Haffner S.M. Insulin resistance, inflammation and the prediabetic state. Am. J. Cardiol. 92 Suppl. 4 (2003) 18J-26J
26. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., et al. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353 (1999) 1649-1652